Abstract:Genetic engineering, which was first developed in the 1980s, allows for specific additions to animals’ genomes that are not possible through conventional breeding. Using genetic engineering to improve agricultural animals was first suggested when the technology was in the early stages of development by Palmiter et al. (Nature 300:611–615, 1982). One of the first agricultural applications identified was generating transgenic dairy animals that could produce altered or novel proteins in their milk. Human milk contains high levels of antimicrobial proteins that are found in low concentrations in the milk of ruminants, including the antimicrobial proteins lactoferrin and lysozyme. Lactoferrin and lysozyme are both part of the innate immune system and are secreted in tears, mucus, and throughout the gastrointestinal (GI) tract. Due to their antimicrobial properties and abundance in human milk, multiple lines of transgenic dairy animals that produce either human lactoferrin or human lysozyme have been developed. The focus of this review is to catalogue the different lines of genetically engineered dairy animals that produce either recombinant lactoferrin or lysozyme that have been generated over the years as well as compare the wealth of research that has been done on the in vitro and in vivo effects of the milk they produce. While recent advances including the development of CRISPRs and TALENs have removed many of the technical barriers to predictable and efficient genetic engineering in agricultural species, there are still many political and regulatory hurdles before genetic engineering can be used in agriculture. It is important to consider the substantial amount of work that has been done thus far on well established lines of genetically engineered animals evaluating both the animals themselves and the products they yield to identify the most effective path forward for future research and acceptance of this technology.

A CLINICAL REVIEW OF THE SINGLE BREATH METHOD OF MEASURING THE DIFFUSING CAPACITY OF THE LUNGS.

A novel promoterless gene targeting vector to efficiently disrupt PRNP gene in cattle.

Gene targeting by TALEN-induced homologous recombination in goats directs production of β-lactoglobulin-free, high-human lactoferrin milk

Human lactoferrin efficiently targeted into caprine beta-lactoglobulin locus with transcription activator-like effector nucleases

Ligation of RAGE with ligand S100B attenuates ABCA1 expression in monocytes.

Frequently cited references in contemporary pharmacokinetics.

Efficient introgression of allelic variants by embryo-mediated editing of the bovine genome

Editing livestock genomes with site-specific nucleases.

Refactoring of Heterogeneous Meta-Program into k-stage Meta-Program

Advances in Genetic Engineering of Domestic Animals

Optimizing Genome Editing in Bovine Cells: A Comparative Study of Cas9 Variants and CRISPR Delivery Methods

CRISPR/Cas9-mediated knock-in strategy at the Rosa26 locus in cattle fetal fibroblasts

Knock-in fibroblasts and transgenic blastocysts for expression of human FGF2 in the bovine β-casein gene locus using CRISPR/Cas9 nuclease-mediated homologous recombination

Efficient and Specific Generation of MSTN-Edited Hu Sheep Using C-CRISPR

Burst pulses of Guiana dolphin (Sotalia guianensis) in southeastern Brazil.

Production of human lactoferrin and lysozyme in the milk of transgenic dairy animals: past, present, and future

CRISPR/Cas9-mediated sheep MSTN gene knockout and promote sSMSCs differentiation

Using a modified piggyBac transposon‐combined Cre/loxP system to produce selectable reporter‐free transgenic bovine mammary epithelial cells for somatic cell nuclear transfer

Screening somatic cell nuclear transfer parameters for generation of transgenic cloned cattle with intragenomic integration of additional gene copies that encode bovine adipocyte-type fatty acid-binding protein (A-FABP)

Pore water sampling in acid sulfate soils: a new peeper method.

Application of genome editing in farm animals: cattle